Table 2 LegVAS, BackVAS, and ODI

Baseline

59.67 ± 19.68

Reference

65.27 ± 15.32

Reference

Reference

1

2wk

21.33 ± 16.85

-38.33 (-47.02, -29.65)

37.27 ± 19.03

-28 (-35.91, -20.09)

10.33 (-1.35, 22.02)

0.083

6wk

36.36 ± 16.9

-25.19 (-34.82, -15.56)

22.67 ± 15.34

-42.6 (-50.51, -34.69)

-17.29 (-29.64, -4.95)

0.006*

12wk

32 ± 11.35

-27.78 (-37.72, -17.83)

18.33 ± 13.58

-46.93 (-54.84, -39.02)

-19.13 (-31.7, -6.56)

0.003*

24wk

30 ± 7.45

-29.78 (-39.72, -19.83)

15.33 ± 9.9

-49.93 (-57.84, -42.02)

-20.13 (-32.7, -7.56)

0.002*

Back VAS

Triamcinolone (n = 15)

Mean change

(95%CI)

PRP

(n = 15)

Mean change

(95%CI)

Mean difference

Between groups (95%CI)

p-value

Baseline

73 ± 13.86

Reference

64.27 ± 17.53

Reference

Reference

1

2wk

32.8 ± 24.84

-40.2 (-50.26, -30.14)

34.8 ± 19.37

-29.47 (-36.84, -22.1)

10.73 (-1.52, 22.99)

0.086

6wk

35 ± 17.18

-38.36 (-49.48, -27.25)

25 ± 13.09

-39.27 (-46.64, -31.9)

-0.82 (-13.76, 12.12)

0.901

12wk

29 ± 13.08

-42.78 (-54.26, -31.31)

20.67 ± 8.84

-43.6 (-50.97, -36.23)

-1.02 (-14.19, 12.16)

0.88

24wk

28.5 ± 10.29

-43.28 (-54.76, -31.81)

17.8 ± 11.33

-46.47 (-53.84, -39.1)

-3.38 (-16.56, 9.8)

0.615

ODI

Triamcinolone (n = 15)

Mean change

(95%CI)

PRP

(n = 15)

Mean change

(95%CI)

Mean difference

Between groups (95%CI)

p-value

Baseline

43.13 ± 10.81

Reference

44.73 ± 10.71

Reference

Reference

1

2wk

23.19 ± 15.84

-19.93 (-25.95, -13.92)

30.6 ± 12.56

-14.13 (-18.77, -9.5)

5.8 (-1.69, 13.29)

0.129

6wk

27 ± 13.3

-18.73 (-25.42, -12.03)

25.67 ± 11.61

-19.07 (-23.7, -14.43)

-0.09 (-8.03, 7.84)

0.981

12wk

21.64 ± 7.92

-22.75 (-29.67, -15.83)

18.07 ± 8.06

-26.67 (-31.3, -22.03)

-3.77 (-11.85, 4.32)

0.361

24wk

21.3 ± 5.21

-23.09 (-30.01, -16.17)

15.07 ± 7.79

-29.67 (-34.3, -25.03)

-6.42 (-14.51, 1.66)

0.120